Related Experiment Video

Updated: Mar 19, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

New structural and functional insight into the regulation of Ras

Yoshihito Kano1, Jonathan D Cook2, Jeffrey E Lee2

  • 1Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, Ontario, M5S1A8, Canada; Department of Biochemistry, University of Toronto, 1 King's College Circle, Toronto, Ontario, M5S1A8, Canada.

Seminars in Cell & Developmental Biology
|June 15, 2016
PubMed

Insights

Ras mutations drive many cancers, but direct inactivation strategies have failed. This review explores Ras regulation by tyrosine kinases and phosphatases, offering new therapeutic insights for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • RAS mutations are frequent in human cancers, notably lung (25%) and pancreatic (>90%).
  • Ras GTPase acts as a molecular switch in crucial eukaryotic cellular signaling pathways.
  • Current anti-cancer strategies targeting Ras directly have yielded unsatisfactory clinical outcomes.

Purpose of the Study:

  • To review the role of non-receptor tyrosine kinases and phosphatases in Ras regulation.
  • To discuss the function and structure of these regulatory components in the context of oncogenesis.
  • To explore novel therapeutic strategies for Ras-driven cancers.

Main Methods:

  • Literature review of studies on Ras signaling pathways.
  • Analysis of structural and functional data of non-receptor tyrosine kinases and phosphatases.
  • Synthesis of information regarding the interplay between Ras, kinases, and phosphatases.

Main Results:

  • Non-receptor tyrosine kinases and phosphatases represent a key regulatory layer for Ras activity.
  • These enzymes are implicated in the oncogenic potential of Ras signaling.
  • Understanding their function and structure is crucial for developing effective therapies.

Conclusions:

  • Targeting the non-receptor tyrosine kinase and phosphatase regulation of Ras offers a promising avenue for cancer therapy.
  • Further research into the structure-function relationships of these regulators is warranted.
  • This review provides a foundation for developing novel anti-cancer drugs against Ras-driven malignancies.
Keywords:
GTPase cycleRasShp2SrcY32

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.9K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
The Ras Gene02:38

The Ras Gene

2.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.4K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
10.2K